Last week GREG held its annual Consortium Meeting in Copenhagen on 6–7th May 2026, bringing together partners from across the project to review progress, align on next steps, and strengthen collaboration.
The meeting opened with an overview of achievements to date, including updates on use case selection and early lessons learned. Discussions highlighted the structured process behind identifying use cases, along with key legal and financial considerations. Selected use cases were presented, setting the stage for further work on feasibility and implementation.
A major focus was the Feasibility Assessment, which examined methodological, resource, and data-related aspects across multiple phases, from study exploration through to dissemination. This work is expected to play a critical role in shaping the guidance for future Real-World Evidence.
Project coordination and reporting milestones were also reviewed, alongside updates on deliverables submitted for evaluation. Participants explored how existing regulatory and health technology assessment (HTA) resources can be integrated into GREG, and reviewed progress on developing real-world data guidance and a preliminary knowledge base to support decision-making, a key output of GREG.
The importance of engaging regulatory and HTA stakeholders was reinforced, with plans to involve them as reviewers, advisors, and contributors to identifying gaps and refining outputs. Communication, training, and sustainability activities were also highlighted, including growing outreach efforts, future stakeholder engagement strategies, and the development of learning materials and long-term project exploitation.
The second day focused on strengthening patient involvement through the Patient Advisory Group, including how patient perspectives will be integrated across work packages and decision-making processes.
The consortium also received feedback from the project’s Scientific Officer, emphasizing both the achievements of the first year and the importance of continued collaboration to address upcoming challenges.
After two intense days of discussions, the meeting concluded with a renewed sense of direction and momentum, as partners continue working toward advancing Real-World Evidence for regulatory and HTA decision-making.
Stay tuned for more updates—and see how GREG is redefining RWE for regulatory success!
